|
Session 1-2: Sustained-release, Controlled-release, and Modified-release |
|
|
Day 2: Morning, July. 16, 2021 |
|
|
Chair |
Dr. Emilia Barcia, Professor, University Complutense of Madrid, Spain
|
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Vaginal Rings: Expanding Drug Delivery Options for Women Dr. David R. Friend, Chief Scientific Officer, Dare Bioscience, USA |
|
09:00-09:25 |
Title: The Potential of Micro- and Nanosystems for Neurodegenerative Diseases Dr. Emilia Barcia, Professor, University Complutense of Madrid, Spain |
|
09:25-09:50 |
Title: A Statistical Mechanical Model for Drug Release: Scaling and Universality Dr. Fernando Oliveira, Instituto de Física, Universidade de Brasília, Brazil |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55
|
Title: Relative Importance of Bioavailability and Bioassesibility for Efficient Absorption of Target Nutrients Dr. Anubhav Pratap Singh, Professor, University of British Columbia, Canada |
|
10:55-11:20
|
Title: Formulation Insights for Solubility Enhancement: Striking the Right Balance Dr. Sanjay Konagurthu, Senior Director, PDS Global Science and Technology, Thermo Fisher Scientific, USA |
|
11:20-11:45
|
Speech Opportunity Available |
| 11:45-12:10 |
Title: Progress of Brain-targeting of the Novel Zolmitriptan Novasomes via the Nasal Route: In-vitro and In-vivo Assessment Dr. Ehab Rasmy Bendas, Professor, Clinical Pharmacy Department, Future University, Egypt |
|
Session 2-2: Nanotechnologies for Drug Delivery |
|
|
Day 2: Morning, July. 16, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: TBD Dr. Imran Y. Saleem, Professor, Liverpool John Moores University, UK |
|
09:00-09:25 |
Title: Opiod Crisis: The Potential of Nanodrugs Targeting Peripherical Pain Relief Dr. Sam Dylan More, CEO, DendroPharm, Germany |
|
09:25-09:50 |
Title: Biopolymers in Nanotechnology Dr. Mont Kumpugdee Vollrath, Professor, Beuth Hochschule fur Technik Berlin, Germany |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
| 10:30-11:55 |
Speech Opportunity Available |
| 10:55=11:20 |
Title: Tuning the Size and Composition of Nanohydrogels using a “Phantom Monomer” for Controlled Drug Delivery Dr. Gerardo Byk, Associate Professsor, Department of Chemistry, Bar Ilan University, Israel |
| 11:20-11:45 |
Title: TBD Dr. Frank Watt, Visiting Professor, National University of Singapore, Singapore |
| 11:45-12:10 |
Speech Opportunity Available |
|
Session 3-2: Inhalation & Respiratory Drug Delivery |
|
|
Day 2: Morning, July. 16, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: What Means Bioequivalence and Therapeutic Equivalence for Inhalation Products? Dr. JörgSchiewe, BoehringerIngelheimPharma GmbH & Co. KG, Germany |
|
09:00-09:25 |
Title: FRI: Combining Local Depostion-, Ventilation- and Bloodflow Data to Optimize Drug Development in the Lung Dr. Jan De Backer, CEO, FluidDA nv, Belgium |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Title: A Cell Stabilized Microcrystalline Formulation for Inhaled Drug Delivery Dr. Gus R. Rosania, Associate Professor, University of Michigan, USA |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 |
Speech Opportunity Available |
| 10:55-11:20 |
Title: Biophysical and Chemical Stability of Surfactant/Budesonide and the Pulmonary Distribution Following Intra-tracheal Administration Dr. Tsu-Fu Yeh, Professor, Taipei Medical University, Taiwan |
| 11:20-11:45 |
Speech Opportunity Available |
|
Session 4-1: Polymers for Drug Delivery |
|
|
Day 2: Morning, July. 16, 2021 |
|
|
Chair |
Dr. Andreas Nixdorf, Business Development Manager, Extractables & Leachables Testing, SGS Life Science Services, Germany |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: TBD Dr. Andreas Nixdorf, Business Development Manager, Extractables & Leachables Testing, SGS Life Science Services, Germany |
|
09:00-09:25 |
Title:Topological Structure Changing Polymeric-DNA Construction for Nano to Microstructures for Drug Deliveryand Repair Mechanism Dr. Leela Rakesh, Professor, Central Michigan University, USA |
|
09:25-09:50 |
Title: Its Time to Rethink Glass: Transformative Parenteral Packaging through Advanced Materials Science Mr. Holger Krenz, Vice President Applications Development Europe, SiO2 Medical Products, Germany |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
Session 1-3: Transdermal and Intradermal Delivery |
|
|
Day 2: Afternoon, July. 16, 2021 |
|
|
Chair |
Dr. Marta Venczel, Head of Biopharmacy, Pharmaceutical Sciences Operations Frankfurt, Sanofi, Germany |
|
Time |
|
|
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
Title: Transdermal Delivery of Cannabidiol Dr. Ludwig Weimann, CSO, Remy Biosciences, Inc., Irvine, CA, USA |
|
09:00-09:25 |
Title:Biopharmaceutical Evaluation of Subcutaneously Injected Formulations Dr. Marta Venczel, Head of Biopharmacy, Pharmaceutical Sciences Operations Frankfurt, Sanofi, Germany |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Title: TcVac1 Vaccine Delivery by Intradermal Electroporation Enhances Vaccine Induced Immune Protection against TrypanosomaCruzi Infection in Mice Dr. Juan Carlos Vázquez Chagoyán, Professor, Universidad Autónoma del Estado de México, Mexico |
|
10:15-10:30 |
Coffee Break |
| 15:30-15:55 | Title: Transdermal Drug Delivery - Still Fashionable? Dr. Sandra Wiedersberg, Director, Head of Laboratory PhE I/5, Pharmaceutical Development R&D, LTS Lohmann Therapie-Systeme AG, Germany |
| 15:55-16:20 |
Title: New Dimensions in Transdermal Drug Delivery Dr. Bruce K. Redding, Jr., CEO, Transdermal Specialties Global, USA |
|
16:20-16:45 |
Title: Drug Delivery across the Skin Barrier Using Biocompatible Nanocarriers Dr. Fiorenza Rancan, Assistant Professor, Charité – Universitätsmedizin Berlin, Germany |
| 16:45-17:10 |
Speech Opportunity Available |
|
Session 2-3: Nucleic Acid Delivery and Vaccine Delivery |
|
|
Day 2: Afternoon, July. 16, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: Safe Delivery of Nucleic Acid Cargoes Using Anionic Carriers Dr. Steffen Panzner, Founder and Managing Director, Lipocalyx GmbH, Germany |
|
14:00-14:25 |
Title: Development of New Polymer-Based Strategies for Gene and Drug Delivery Dr. Anja Traeger, Group Leader,Institute for Organic Chemistry and Macromolecular Chemistry (IOMC), Jena Center for SoftMatter (JCSM), Friedrich Schiller University Jena, Germany |
|
14:25-14:50 |
Speech Opportunity Available |
|
14:50-15:15 |
Title: Design and Assembly of Multilevel Lipid Nanoconstructions for Nucleic Acids Delivery into Eukaryotic Cells Dr. Ilya Dovydenko, Researcher, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Science, Russia |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Title: Development of Stereopure Nucleic Acid Therapeutics Dr. Chandra Vargeese, Senior Vice President and Head of Research, WaVe Life Sciences, USA |
| 15:55-16:20 |
Speech Opportunity Available |
| 16:20-16:45 |
Speech Opportunity Available |
|
Session 3-3: Brain Drug Delivery |
|
|
Day 2: Afternoon, July. 16, 2021 |
|
|
Chair |
Call for Chair |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Speech Opportunity Available |
|
14:00-14:25 |
Title: TBD Dr. Fred Monsuur, Excipient Development & TCS Manager, Grace Materials Technologies, USA |
|
14:25-14:50 |
Title: TBD Dr. Pierre-Yves Renard, Professor, COBRA (UMR 6014), INSA Rouen, CNRS, Normandie University, France |
|
14:50-15:15 |
Title: TBD Dr. Zhang-Jin Zhang, Professor, The University of Hong Kong, China |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Title: Drug Safety of our New Invention of Administration Route of Psilocybin in Depression and other Indications Dr. Jukka Karjalainen, Chief Medical Officer, Cybin Corp, Canada |
| 15:55-16:20 |
Title: Unprecedented Carrier Technology for Nose to Brain Delivery - Creating Therapies for CNS Diseases with Dr. Claudia Mattern, Professor&Chief Science Officer MetP® Pharma AG, Switzerland |
| 16:20-16:45 |
Title: Diagnosis and Treatment of Cerebral Malaria Dr. Jacob Golenser, Department of Microbiology and Molecular Genetics, The Kuvin Centre for the Study of Infectious and Tropical Diseases, The Hebrew University of Jerusalem-Hadassah Medical School, Israel |
| 16:45-17:10 |
Speech Opportunity Available |
|
Session 4-2: Nanoparticles and Nanocapsules in Drug Delivery |
|
|
Day 2: Afternoon, July. 16, 2021 |
|
|
Chair |
Dr. Ethel J. Ngen, Research Faculty, Johns Hopkins University School of Medicine, USA |
|
Time |
|
|
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
Title: High Performance Locoregional Solutions to Problematic Cancers by Novel Nanotechnologies Dr. Khursheed Anwer, Executive Vice President & Chief Science Officer, Celsion Corporation, USA |
|
14:00-14:25 |
Title: Physicochemical Characterization of Liposomes in Externally Triggered Drug Delivery Dr. Lasse Murtomäki, Professor, Aalto University, Finland |
|
14:25-14:50 |
Title: Strategies to Enhance the Delivery of Nanoparticles to Tumors Dr. Ethel J. Ngen, Research Faculty, Johns Hopkins University School of Medicine, USA |
|
14:50-15:15 |
Title: Gold Nanoparticles: New Approach to siRNA Delivery Dr. Elena Ryabchikova, Professor, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Science, Russia |
|
15:15-15:30 |
Coffee Break |
| 15:30-15:55 |
Title: Drug Loaded Bioresorbable Sol Gel Derived Fibers-A Novel Platform Technology in Regenerative Therapies Dr. Sofia Dembski, Head Biomaterials, Translation, Fraunhofer Institute for Silicate Research ISC, Germany |
| 15:55-16:20 |
Title: Functionalized Harmonic Nanoparticles for Bioimaging and NIR-light Triggered Drug Delivery Dr. Sandrine Gerber, Professor, EPFL Lausanne, Switzerland |
| 16:20-16:45 |
Speech Opportunity Available |
| 16:45-17:10 |
Speech Opportunity Available |
|
© 2003-2021 All rights reserved by BIT Congress |